INTRODUCTION
============

The global yearly rate of head and neck malignancies is at a staggering more than 550,000 victims with nearly 300,000 becoming deceased \[[@b1-arm-2018-42-6-846]\]. These statistics make head and neck cancer (HNC) the sixth global common cancer by rate \[[@b2-arm-2018-42-6-846],[@b3-arm-2018-42-6-846]\]. Trismus can be triggered by various reasons including but not limited to dental epidemics, tonsils abscesses, injuries of temporomandibular joint (TMJ) muscles, infectious diseases of the mandible, maxillofacial congenital deformities, or treatment radiotherapy for HNC \[[@b4-arm-2018-42-6-846],[@b5-arm-2018-42-6-846]\]. Trismus was identified to develop at a rate of 5%--38% \[[@b6-arm-2018-42-6-846]\] after head and neck surgeries. Cancerrelated trismus occurs either as a result of the tumor itself or due to its treatment \[[@b7-arm-2018-42-6-846]\]. Tumor cells insinuate the muscles adjoining the TMJ, causing a reactive contraction of the muscles that act to close the mouth. Furthermore, the formation of scar and fibrous tissue, which correlates with using radiotherapy for the treatment of such tumors, constrained the movements of the mouth \[[@b8-arm-2018-42-6-846],[@b9-arm-2018-42-6-846]\]. Multiple approaches have been recommended for the management of trismus including therapeutic exercises, electrotherapeutic modalities, computer-based equipment, and in some cases surgical interventions \[[@b10-arm-2018-42-6-846],[@b11-arm-2018-42-6-846]\]. Other modalities such as stretching exercises that incorporate moist heat, low intensity ultrasound (LIUS) and transcutaneous electrical nerve stimulation (TENS) are preferred due to their ease of application and efficiency \[[@b12-arm-2018-42-6-846],[@b13-arm-2018-42-6-846]\].

LIUS is a modality used for the treatment of many skeletal muscle dysfunctions. Its mechanical energy, is transferred in the manner of acoustic compression waves to evoke thermal and mechanical physiological changes in the targeted tissue. This particular feature makes LIUS a common modality used for treatment. It was assumed that the mechanical strains of ultrasound provoke biochemical changes which accelerate the tissue repair \[[@b14-arm-2018-42-6-846]\]. The thermal physiological changes of LIUS include the increment of local tissue temperature, plenty of blood flow and improvement of the flexibility and extensibility of tissue with diminished fluid viscosity \[[@b15-arm-2018-42-6-846]\] making LIUS applicable in the management of trismus condition and for diminishing TMJ pain following HNC.

Neuromuscular stabilization is an example of a manual therapy technique used for the treatment of TMJ dysfunction \[[@b16-arm-2018-42-6-846]\]. The mastication muscles is used to implement a compressive power to the condylar disk through promoting the condylar-disk-eminence integrity and eventually recovering the muscle function. These procedures can additionally be employed as proprioceptive training to develop functional movements and concurrently diminishing pain \[[@b17-arm-2018-42-6-846]\].

Low level laser therapy (LLLT) reduces the inflammatory conditions without adverse consequences by lessening pain and swelling and supporting the repair of the tissue \[[@b18-arm-2018-42-6-846]\]. The force of LLLT in treating pain originating from soft-tissue trauma can be attributed to the indirect reduction of edema, bleeding, neutrophil activity, provocative cytokines and enzymatic action. LLLT reduces swelling and subsequent pain resulting in, enhanced tissue repair since lymphatic vessels regeneration is accelerated and the vascular permeability is minimized \[[@b19-arm-2018-42-6-846]\].

In fact, in the past few years, surgical, medical and conservative approaches have arose to treat trismus and TMJ pain with no predictable results \[[@b20-arm-2018-42-6-846]\]. In order to enhance the speed of recovery of these debilitation problems and to concrete the evidence of both LIUS and LLLT in managing such conditions, the study was monitored and evaluated. The aim of the present study is to compare the effects of LIUS plus traditional exercise therapy (TET), LLLT plus TET, and TET on TMJ pain and trismus following HNC.

MATERIALS AND METHODS
=====================

Subjects
--------

Initially, 70 participants (33 females and 37 males) with trismus and pain following HNC were recruited from the National Cancer Institute in Cairo at the period from April 2016 to February 2017 with 60 of them (27 Females, 33 males) completing the study. The study was performed in accordance with the Declaration of Helsinki and approved by the Local Institutional Review Board of the Faculty of Physical Therapy at Cairo University (No. P.T.REC/012/001868). To detect a difference of 20% in the pain intensity gained by the treatment modalities between groups using visual analog scale (VAS), the study sample size was estimated with a power of 80% and a confidence level alpha (=0.05). Therefore, while the sample size was assumed to be 20 participants per study group, the number was increased to 70 patients for the three groups taking into account the drop out throughout the study time. An informed written consent was signed by every participant while purpose, benefits, and potentials of the current clinical trial interventions were agreed upon with the participants.

Participants underwent physical assessment and their history noted. They were recruited in the study only if their clinical assessments revealed that they suffered from trismus and pain following HNC. Patients who had any medical conditions or health problems that may affect the results of the study as implants, pregnancy, sensitivity to phototherapy, or any neurological condition impacting the facial nerve as Bell's palsy were excluded from the study.

Participants were randomly allocated into three groups of 20 patients. Group A was subjected to LIUS plus TET program that included stretching exercises, passive and active range of motion exercises and strengthening exercises. Group B received LLLT plus TET, whereas group C received only TET. The principal investigator used concealed envelope randomization and the participants were then offered the allocated treatment. Both participants and investigators were blinded during the randomization and allocation processes.

Measurement procedures
----------------------

### Measurement of maximum mouth opening by using VCS

The amount of mouth mandibular opening (MMO) was estimated using the calculation of vertical distance between the incisal ends of upper and lower front teeth. Any incongruity of the mandible throughout opening and closing was also detected. A modified Vernier Caliper recorded the MMO, with the patients supporting their heads alongside a firm wall/surface in an erect position. After confirming the caliper gauge had no missing or worn out numbers and no scratches of the marking lines, patients were instructed to open their mouth as wide as they could, while the investigator estimated the maximum vertical distance between the incisal edges of the maxillary central incisor and the mandibular central incisor at the midline \[[@b21-arm-2018-42-6-846]\]. Three readings were recorded per patient and the average determined.

### UW-QOL questionnaire

Based on our research, there is no standard questionnaire that should be used for the measurement of quality of life \[[@b22-arm-2018-42-6-846]\]. The one frequently used by clinicians in the United Kingdom is (UW-QOL), notably due to its simplicity and accuracy \[[@b23-arm-2018-42-6-846]\]. The fourth version of the UW-QOL questionnaire comprises of 12 sole question fields; pain, appearance, activity, recreation, swallowing, chewing, speech, shoulder, taste, saliva, mood, and anxiety. These fields require between 3 and 6 answer options all of which are scored consistently from 0 (worst) to 100 (best) according to the grading of response \[[@b24-arm-2018-42-6-846]\].

### Measurement of pain intensity using VAS

VAS is a continuous horizontal line of length (10 cm) starting with no pain at the left side and gradually increasing pain towards the end of the line at the right side. A translated Arabic version of VAS was used \[[@b25-arm-2018-42-6-846]\].

Baseline measurements were taken at the beginning of the study and outcome measurements were carried out on 4 weeks later for each patient. To avoid inter examiner variability, all measurements were performed by a single examiner

Treatment procedures
--------------------

### LIUS procedure

LIUS therapy was conducted by a therapeutic ultrasound machine (Sonicator 740; Mettler Electronics Corp., Anaheim, CA, USA; output of AC=230 V \@50/60 Hz, max power consumption=73 W, and frequency=1 MHz). Patients were encouraged to sit in a comfortable position while the LIUS therapy was applied at frequency of 1 MHz, pulsed mode 60% and a dose of 1.0 W/cm^2^ for 5 minutes. unilaterally over the affected masseter muscle orally, 5 times a week for 4 consecutive weeks.

### LLLT procedure

LLLT was conducted by use of laser equipment (Electro Medical Supplies (Greenham) Ltd., Wantage, Oxfordshire, UK). After preparation of the patient, goggles were provided to both patient and therapist as protective wear for the eyes, the infrared laser of wavelength (950 nm), output power 15 mW, pulsed 80%, at a dose of 4.3 J/cm^2^, max energy density (7.6 J/cm^2^) for 6 minutes. extra orally over the lateral aspect of the lower jaw unilaterally exactly over the affected masseter muscle, 5 times a week for 4 consecutive weeks.

TET program
-----------

The traditional exercise therapy was given to the three groups of the study as a form of passive and active range of motion, stretching exercises, and resistive mouth exercises. Each type of exercise was performed for a duration of 6 seconds and repeated 10 times. The exercises were performed twice a day, 5 times a week for 4 consecutive weeks \[[@b26-arm-2018-42-6-846],[@b27-arm-2018-42-6-846]\].

The sequence of the treatment for patients in group A involved the LIUS followed by 5-minute rest period and then TET while the second dose of TET was done as a home care session. For patients in group B, the LLLT was administered, followed by 5-minute rest period and then TET and the second dose of TET as a home care session as well. Group C received only TET as a home care program while visiting the outpatient clinic once a week. All patients were given extensive explanation on measurements and treatment procedures prior to engaging in the treatment program.

Statistical analysis
--------------------

The averages and standard deviations for age, weight, height, and body mass index (BMI) were used as basic references for correlating data to estimate the central tendency. A paired t-test was used to obtain the differences within each group between baseline and post- treatment results, and Pearson chi-squared test was used to test the categorical variable of either female or male). Oneway analysis of variance (ANOVA) and post-hoc test were used to assess intergroup differences in various measurements. The results were considered statistically significant if the p-value less than 0.05. SPSS version 20 (IBM, Armonk, NY, USA) was used to analyze the data.

RESULTS
=======

Seventy HNC survivors were invited to join this study based on the eligibility criteria of experiencing trismus and pain following HNC. Ten of them did not complete the study and were excluded because of various causes. Two did not meet the inclusion criteria and one declined to participate. Based on this, the final incorporated participants were 67 where they were allocated randomly into three groups. Group A and C both begun with 22 participants, while group B had 23 participants. Throughout the interventions, 7 participants dropped out; 2 of them joined another hospital and declined the treatment interventions, one experienced unprecedented medical problems, and another stopped the intervention because of unavailability of transportation. Three other participants changed their residential zones posing a challenge to their commitment. The final tally of participants reduced to 60 as is shown in [Fig. 1](#f1-arm-2018-42-6-846){ref-type="fig"}.

It was proven that no significant differences in the bio demographic data of the three groups regarding age, weight, height, sex variable, and BMI (p\>0.05) existed, indicating the uniformity and homogeneity of the participants as shown in [Table 1](#t1-arm-2018-42-6-846){ref-type="table"}.

The statistical analysis did not present any notable differences at the beginning of the study for UW-QOL questionnaire, VAS and VCS among all groups (p\>0.05) as shown in [Table 2](#t2-arm-2018-42-6-846){ref-type="table"}.

At the end of the treatment, the three groups showed noteworthy statistical differences using ANOVA test and the post-hoc test in favor of group A (p\<0.05) for UWQOL questionnaire as shown in [Table 3](#t3-arm-2018-42-6-846){ref-type="table"}.

For VAS, a remarkable difference was detected in favor of group A compared to group B and group C, while there were very minimal differences between groups B and C. Moreover, the results of VCS revealed major differences in group B compared to group C (p\<0.05), and negligible differences between groups A and B as shown in [Table 3](#t3-arm-2018-42-6-846){ref-type="table"}.

DISCUSSION
==========

In this study, a comparative analysis was performed to examine the effects of LIUS along with TET, LLLT along with TET, and TET on TMJ trismus and pain following HNC. At the end of the treatment, it was established that all the three treatment approaches were beneficial in managing TMJ dysfunctions based on the results of the UW-QOL questionnaire, VAS, and VCS. However, the highest improvement in all outcomes was observed in the group underwent LIUS along with TET.

In a study conducted by Lee et al. \[[@b28-arm-2018-42-6-846]\], it was concluded that trismus has a deteriorating effect on mouth function and the quality of life and consequently mouth exercises should be prescribed to improve the mouth function. There exists an alarming rate of trismus in subjects with HNC. Trismus critically diminishes the health-related quality of life and negatively affects daily living activities of subjects with HNC \[[@b29-arm-2018-42-6-846]\].

The current study showed remarkable improvement of patients' trismus and pain after the various therapy modalities. These results are parallel to a study conducted by Carrillo et al. \[[@b30-arm-2018-42-6-846]\] who reported that LLLT had a more impressive positive effect on trismus after third molar operation as compared to its placebo application which used He-Ne laser with a wavelength of 633 nm, a power of 0.3 W/cm^2^, and a dose of 10 J/cm^2^ at different six points around the operation site with a spot of 1.5 mm.

A different study conducted parallel to this one by Zecha et al. \[[@b31-arm-2018-42-6-846]\] observed that LLLT has a great effect in managing the side effects following chemoradiation therapy of HNC including trismus, dysgeusia, dysphagia, lymphedema, and speech problems.

Contrary to the above study, studies conducted by Roynesdal et al. \[[@b32-arm-2018-42-6-846]\] and Fernando et al. \[[@b33-arm-2018-42-6-846]\] reported that LLLT has no effect in the treatment of pain, swelling and trismus in TMJ dysfunction.

LIUS is considered as one of the electrophysiological modalities that ceases inflammation, enhances muscular relaxation and speeds up the blood flow to the target muscle and tendons. These physiological effects are elicited by increasing the internal tissue temperature compared with the adjacent tissue \[[@b34-arm-2018-42-6-846]\]. Gray et al. \[[@b12-arm-2018-42-6-846]\] conducted a study to compare the effects of short-wave diathermy, LIUS and LLLT in patients with TMJ dysfunction. They found no notable difference in the results of all treatment modalities. Nevertheless, these modalities induced significant improvements compared with its placebo treatment.

The present study ran concurrently with a one conducted by Rai et al. \[[@b35-arm-2018-42-6-846]\]; they reported that therapeutic ultrasound is effective in the treatment of maxillofacial disorders through lessening pain and enhancing the healing property of soft tissues.

In adversary, Grieder et al. \[[@b36-arm-2018-42-6-846]\] conducted a study regarding the assessment values of ultrasound in the treatment of TMJ dysfunction and concluded that ultrasound was not effective alone in the treatment of such problems.

Oral exercise therapy including passive and active movements, stretching and strengthening exercises have proven to beneficially decrease the signs and symptoms related to TMJ dysfunction since they improve the mouth opening and mandibular movements \[[@b37-arm-2018-42-6-846],[@b38-arm-2018-42-6-846]\]. In our trial, the patients were urged to use such types of exercises which reflected an improvement of the total scores of VAS, UW-QOL, and VCS at the end point of the treatment protocol.

The observed improvement in outcomes of patients treated by LIUS plus TET may be attributed to the ability of the ultrasound to: improve blood circulation to the target tissue, produce micro massage, remove waste products, accelerate the lymphatic drainage, improve the metabolic activities and increase the extensibility of soft tissue. Additionally, lessening of pain may be attributed to increased blood flow resulting in washing up of metabolites and the chemical mediators flow \[[@b39-arm-2018-42-6-846]\].

The study revealed that LIUS has a more superior effect when combined with the TET program in comparison to LLLT when combined with the same types of exercises in the treatment of trismus and its related pain among patients with HNC.

Given that there was no control group in this study, larger sample sizes are recommended for other prospective trials in order to overcome the limitations and challenges experienced during this study.

In conclusion, based on the results of this study, LIUS, LLLT, and TET emerge as valuable treatment methods of trismus and pain for patients following HNC. Despite a small sample size, this particular study proved that combined program of LIUS and TET had more superior effect when compared to LLLT and/or TET in the treatment of TMJ pain and trismus following HNC and can be considered as adjunct methods in the treatment of such problems.

No potential conflict of interest relevant to this article was reported.

![Flowchart diagram of the study. LIUS, low intensity ultrasound; TET, traditional exercise therapy; LLLT, low level laser therapy.](arm-2018-42-6-846f1){#f1-arm-2018-42-6-846}

###### 

Demographics of participants

  Variable        Group A      Group B      Group C       p-value
  --------------- ------------ ------------ ------------- ---------
  Age (yr)        61.00±6.16   60.75±5.09   62.85±5.77    0.450
  Height (m)      1.69±0.010   1.68±0.011   1.69± 0.010   0.915
  Sex                                                     0.817
   Male           11           10           12            
   Female         9            10           8             
  Weight (kg)     74.20±5.81   76.55±5.75   76.35±6.33    0.392
  BMI (kg/m^2^)   25.99±1.95   27.10±2.90   26.88±2.03    0.288

Values are presented as mean±standard deviation.

BMI, body mass index.

###### 

Comparisons of UW-QOL, VAS, and VCS pre- and post-treatment for all groups

  Variable   Group   Pre             Post                                                           p-value
  ---------- ------- --------------- -------------------------------------------------------------- -------------------------------------------------------------
  UW-QOL     A       40.65±8.32      80.80±8.81                                                     \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
             B       41.70±10.59     73.30±4.95                                                     \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
             C       39.15±9.29      50.00±7.97                                                     \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
                     p=0.694         p\<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^   
  VAS (cm)   A       7.75±1.41       2.65±1.50                                                      \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
             B       7.55±1.61       3.85±1.66                                                      \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
             C       7.70±1.08       4.80±1.54                                                      \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
                     p=0.893         p\<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^   
  VCS (mm)   A       25.50±6.77068   48.60±11.57                                                    \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
             B       23.65±5.42193   44.40±9.12                                                     \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
             C       24.10±4.95134   34.45±5.36                                                     \<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^
                     p=0.574         p\<0.001^[\*](#tfn1-arm-2018-42-6-846){ref-type="table-fn"}^   

Values are presented as mean±standard deviation.

UW-QOL, University of Washington-Quality of Life; VAS, visual analog scale; VCS, Vernier caliper scale.

p\<0.05.

###### 

Mean differences between the three groups post-treatment

  Variable   Group A vs. Group B                                         Group A vs. Group C                                         Group B vs. Group C                                         p-value
  ---------- ----------------------------------------------------------- ----------------------------------------------------------- ----------------------------------------------------------- -------------------------------------------------------------
  UW-QOL     7.50^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^    30.80^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^   23.30^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^   \<0.001^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^
  VAS (cm)   -1.20^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^   -2.15^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^   -0.95                                                       \<0.001^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^
  VCS (mm)   4.20                                                        14.15^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^   9.95^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^    \<0.001^[\*](#tfn2-arm-2018-42-6-846){ref-type="table-fn"}^

UW-QOL, University of Washington-Quality of Life; VAS, visual analog scale; VCS, Vernier caliper scale.

p\<0.05.
